The chemical reactivity of naphthols and their derivatives toward α-cyanocinnamonitriles and ethyl α-cyanocinnamates: A review of synthesis, reactions and applications of naphthopyrano by El-Wahab, Ashraf Hassan Fekry Abd et al.
European	Journal	of	Chemistry	4	(4)	(2013)	467‐483	
European	Journal	of	Chemistry	
ISSN	2153‐2249	(Print)	/	ISSN	2153‐2257	(Online)		2013	EURJCHEM	
DOI:10.5155/eurjchem.4.4.467‐483.775	
	
	
	
	
European	Journal	of	Chemistry	
Journal	homepage:	www.eurjchem.com	
	 	 	
The	chemical	reactivity	of	naphthols	and	their	derivatives	toward																								
α‐cyanocinnamonitriles	and	ethyl	α‐cyanocinnamates:																																																	
A	review	of	synthesis,	reactions	and	applications	of	naphthopyrano	derivatives	
Ashraf	Hassan	Fekry	Abd	El‐Wahab	a,b,*,	Hany	Mostafa	Mohamed	b,c,		
Ahmed	Mohamed	El‐Agrody	b	and	Ahmed	Hammam	Bedair	b	
a	Chemistry	Department,	Faculty	of	Science,	Jazan	University,	2097,	Jazan,	Saudi	Arabia	
b	Chemistry	Department,	Faculty	of	Science,	Al‐Azhar	University,	11884,	Nasr	City,	Cairo,	Egypt	
c	Chemistry	Department,	Faculty	of	Medicine,	Jazan	University,	82621,	Jazan,	Saudi	Arabia	
*Corresponding	author	at:	Chemistry	Department,	Faculty	of	Science,	Jazan	University,	2097,	Jazan,	Saudi	Arabia.	
Tel.:	+2.0100.8199893;	fax:	+2.02.22629358.	E‐mail	address:	ash_abdelwahab@yahoo.com	(A.H.F.A.	El‐Wahab).	
	
	
	 	
	 	 	
REVIEW	INFORMATION	 	 ABSTRACT
Received:	18	March	2013	
Received	in	revised	form:	17	April	2013	
Accepted:	23	April	2013	
Online:	31	December	2013	
KEYWORDS	
	 This	review	deals	with	synthesis	and	reactions	of	some	naphthopyrano	derivatives	and	their
applications.	 The	 main	 purpose	 of	 this	 review	 is	 to	 present	 a	 survey	 of	 literatures	 on	 the
reactivity	 of	 naphthols	 and	 their	 derivatives	 toward	 α‐cyanocinnamonitrile	 or	 ethyl	 α‐
cyanocinnamate	derivatives	and	the	reactions	of	β‐enaminonitriles	and	β‐enaminoesters	with
different	electrophiles	 followed	by	nucleophilic	reagents.	Some	of	 these	reactions	have	been
applied	successfully	to	the	synthesis	of	biologically	important	compounds.	
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1.	Introduction	
	
Naturally	 occurring	 naphthopyrans	 have	 a	 variety	 of	
interesting	 biological	 activities	 and	 physiological	 properties	
[1,2].	 Among	 these,	mollugin	 (I)	 and	 3,4‐dihydromollugin	 (II)	
were	isolated	from	the	medicinal	plant	Rubia	cordifolia	in	China	
and	 India	 (Figure	1)	 [3].	The	dried	roots	and	rhizomes	of	 this	
plant	 are	 used	 officially	 as	 herbal	 medicine	 in	 the	 Chinese	
Pharmacopeia	for	treating	arthritis,	dysmenorrhea	hemostasis,	
and	 other	 diseases	 [4].	 In	 India,	 this	 plant	 has	 been	 used	 for	
treatment	 of	 rheumatism,	 menstrual	 pain,	 and	 urinary	
disorders	 [5].	 Mollugin	 (I)	 was	 also	 isolated	 from	 rhizome	 of	
Galium	mollugo,	 which	 is	 found	 in	many	 rubiaceous	 herbs	 in	
Europe	 and	 Africa	 [6].	 Mollugin	 (I)	 and	 its	 analogue,	 3,4‐
dihydromollugin	 (II),	 have	 biologically	 interesting	 properties	
such	as	antitumor	[7],	antimutagenic	[8],	antileukemia	[9],	anti‐
inflammatory	[10],	and	antiallergic	activities	[10].		
	 	
	
	
Figure	1.	Structures	of	mollugin	(I)	and	3,4‐dihydromollgin	(II).
	
	
	
2.	Synthesis	of	4H‐naphtho[2,1‐b]pyrans		
	
2.1.	Synthesis	from	6‐methoxy‐2‐naphthol	
	
Condensation	 of	 6‐methoxy‐2‐naphthol	 (1)	 with	 α‐cyano	
cinnamonitriles,	 2a‐f	 and/or	 ethyl	 α‐cyanocinnamates,	 2g‐l,	
afforded	 the	 corresponding	 2‐amino‐4‐aryl‐7‐methoxy‐4H‐
naphtho[2,1‐b]pyran‐3‐carbonitriles,	 3a‐f,	 and	 ethyl‐2‐amino‐
4‐aryl‐7‐methoxy‐4H‐naphtho[2,1‐b]pyran‐3‐carboxy‐lates,	
3g‐l,	 respectively	 [11,12]	 (Scheme	 1).	 A	 mechanism	 for	 the	
piperidine	 catalyzed	 formation	 of	 the	 naphtho[2,1‐b]pyran	
derivatives	3	is	outlined	in	Scheme	2.	
	
	
Scheme	1	
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Scheme	2	
	
2.2.	Synthesis	from	2‐naphthol	
	
a)	Condensation	of	α‐cyano‐p‐methylcinnamonitrile	(2e)	or	
ethyl	α‐cyano‐p‐methylcinnamate	(2h),	with	2‐naphthol	(4)	 in	
ethanolic	 piperidine	 afforded	 2‐amino‐4‐(p‐tolyl)‐4H‐
naphtho[2,1‐b]pyran‐3‐carbonitrile	 (5a)	 and	 ethyl	 2‐amino‐4‐
(p‐tolyl)‐4H‐naphtho[2,1‐b]pyran‐3‐carboxylate	 (5b)	 (Scheme	
3)	[13].	
	
	
	
Scheme	3	
	
b)	 An	 efficient	 bifunctional	 thiourea	 catalyzed	 addition‐
cyclization	reaction	of	arylidenemalononitriles	2	with	2‐naph‐
thol	 (4)	 is	 realized	 under	 mild	 conditions	 to	 afford	 the	
corresponding	 2‐amino‐3‐cyano‐4‐aryl‐4H‐naphtho[2,1‐b]	
pyrans	 (5),	 in	 high	 yields	 and	 moderate	 enantioselectivities	
(Scheme	4	)	[14].	
	
	
	
Scheme	4	
	
c)	 A	 novel	 bifunctional	 thiourea–tertiary‐amine‐catalyzed	
enantioselective	Friedel‐Craft‐type	addition	reaction	of	2‐naph‐
thol	 (4)	 with	 β,γ‐unsaturated	 α‐keto	 ester,	6,	 was	 developed.	
Subsequent	dehydration	of	the	reaction	adducts	with	a	catalytic	
amount	 of	 concentrated	 H2SO4	 in	 a	 one‐pot	 fashion	 readily	
afforded	 a	 series	 of	 new	 optically	 active	 naphthopyran	
derivatives	7	 (Scheme	5),	with	moderate	to	good	yields	(up	to	
91%)	and	enantio	selectivities	(up	to	90%)	[15].	A	mechanism	
for	 the	 bifunctional	 thiourea‐tertiary‐amino‐catalyzed	 forma‐
tion	of	the	naphthopyran	derivatives	7	is	outlined	in	Scheme	6.	
	
	
	
Scheme	5	
	
	
	
Scheme	6	
	
2.3.	Synthesis	from	multicomponent	reactions		
	
a)	Methanesulfonic	 acid	 efficiently	 catalyzes	 the	 one‐pot,	
three	 component	 reaction	 of	 an	 2‐naphthol	 (4),	 aromatic	
aldehyde	 and	 malononitrile	 to	 yield	 2‐amino‐3‐cyano‐4‐aryl‐
4H‐naphtho[2,1‐b]pyrans	(5)	in	good	yields	(Scheme	7)	[16].	A	
mechanism	for	the	methanesulfonic	acid	catalyzed	formation	of	
the	naphtho[2,1‐b]pyran	derivatives	5	is	outlined	in	Scheme	8.	
	
	
	
Scheme	7	
	
	
	
Scheme	8	
	
b)	 Naphtho[2,1‐b]pyran	 derivatives,	 5,	 have	 been	
synthesized	involving	a	one	pot	three‐component	reaction	of	an	
aldehyde,	 malononitrile	 and	 2‐naphthol	 (4)	 using	 catalytic	
amounts	 tetra‐butyl	 ammonium	 bromide	 (TBABr)	 under	
aqueous	conditions	(Scheme	9)	[17].	
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Scheme	9	
	
c)	 Diazabicyclo[2.2.2]octane	 (DABCO)	 has	 been	 used	 as	 a	
mild	and	efficient	catalyst	for	synthesis	of	2‐amino‐3‐cyano‐4‐
aryl‐4H‐naphtho[2,1‐b]pyrans	 (5)	 via	 a	 one‐pot	 three‐compo‐
nent	 reaction	 of	 aromatic	 aldehydes,	 2‐naphthol	 (4),	 and	
malononitrile	 at	 room	 temperature	 [18].	 The	 short	 reaction	
times,	easy	workup,	good	to	excellent	yields,	and	mild	reaction	
conditions	 make	 this	 domino	 Knoevenagel‐Michael	 reaction	
both	practical	and	attractive	(Scheme	10).	A	mechanism	for	the	
DABCO	 catalyzed	 formation	 of	 the	 naphtho[2,1‐b]pyran	
derivatives	5	is	outlined	in	Scheme	11	
	
	
	
Scheme	10	
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Scheme	11	
	
	
d)	 A	 basic	 functionalized	 ionic	 liquid,	 1‐butyl‐3‐methyl	
imidazolium	 hydroxide	 ([bmim]OH),	 catalyzed	 three‐
component	 condensation	 reaction	 of	 aromatic	 aldehydes,	
malononitrile	and	2‐naphthol	(4)	proceeded	rapidly	in	water	at	
reflux	 to	 afford	 corresponding	 2‐amino‐3‐cyano‐4‐aryl‐4H‐
naphtho[2,1‐b]pyrans	 (5)	 in	 high	 yields	 [19].	 The	 greener	
protocol	 was	 found	 to	 be	 fairly	 general	 and	 the	 aqueous	
reaction	 media	 was	 reused	 in	 subsequent	 reactions	 with	
consistent	activity	(Scheme	12).		
	
	
	
Scheme	12	
	
e)	The	model	reaction	was	carried	out	simply	by	mixing	of	
4‐chlorobenzaldehyde,	malononitrile	and	2‐naphthol	(4)	using	
Na2CO3	 as	 catalyst	 afforded	 2‐amino‐3‐cyano‐4‐(p‐chloro	
phenyl)‐4H‐naphtho[2,1‐b]pyran	(5).	In	the	absence	of	catalyst	
no	 reaction	was	 observed	 at	 room	 temperature	 (Scheme	 13)	
[20].	 A	mechanism	 for	 the	 Na2CO3	 catalyzed	 formation	 of	 the	
naphtho[2,1‐b]pyrans	5	is	outlined	in	Scheme	14.	
	
	
	
Scheme	13	
	
	
	
Scheme	14	
	
f)	An	aqueous	solution	of	thiourea	dioxide	(TUD)	was	used	
to	catalyze	a	one‐pot	three‐component	coupling	reaction	of	an	
aromatic	 aldehyde,	 malononitrile,	 and	 2‐naphthol	 (4)	 for	 the	
synthesis	 of	 various	 naphthopyran	 derivatives	 5	 in	 excellent	
yields	 (Scheme	 15)	 [21].	 A	mechanism	 for	 the	 TUD	 catalyzed	
formation	of	the	pyran	derivatives	5	is	outlined	in	Scheme	16.	
	
	
	
Scheme	15	
	
g)	 Naphthopyran	 derivatives	 9	 have	 been	 synthesized	
involving	a	one	pot	 three‐component	 reaction	of	 an	aldehyde,	
active	methylene	substrate	8,	and	2‐naphthol	(4)	catalyzed	by	
Bronsted	acid	molybdophosphoric	acid	[phosphomolybdic	acid	
(PMA)]	(Scheme	17)	[22].	A	mechanism	for	PMA	catalyzed	the	
formation	of	the	pyran	derivatives	9	is	outlined	in	Scheme	18.	
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Scheme	16	
	
	
	
Scheme	17	
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Scheme	18	
	
h)	 The	 condensation	 of	 2‐naphthol	 (4),	 aromatic	 aldehde	
and	5,5‐dimethyl‐1,3‐cyclohexanedione	(10),	the	presence	of	a	
catalytic	 amount	 of	 tungstophosphoric	 acid	 [phosphotungstic	
acid	 (PWA)]	 (5	 mol%)	 at	 60	 °C	 under	 solvent‐free	 condition	
afforded	 12‐(4‐chlorophenyl)‐9,9‐dimethyl‐8,9,10,12‐tetra‐
hydrobenzo‐[a]xanthen‐11‐one	 (12)	 (Scheme	 19)	 [23].															
A	 mechanism	 for	 the	 PWA	 catalyzed	 formation	 of	 the	 pyran	
derivatives	12	is	outlined	in	Scheme	20.		
	
	
	
Scheme	19	
	
	
	
Scheme	20	
	
i)	Treatment	of	2‐naphthol	(4),	triethyl	orthobenzoate	(12)	
and	 acetophenone	 derivatives	 13	 and,	 in	 the	 presence	 of	 a	
catalytic	 amount	 of	bis(2‐anilinotropone)	 Ti	 complex	 afforded	
naphtho[2,1‐b]pyrans	14	 (Scheme	 21)	 [24].	 A	mechanism	 for	
the	bis(2‐anilinotropone)Ti	complex	catalyzed	formation	of	the	
naphthopyran	derivatives	14	is	outlined	in	Scheme	22.	
	
	
	
Scheme	21	
	
	
	
Scheme	22	
	
j)	 A	 facile	 method	 for	 the	 synthesis	 of	 naphthopyran	
derivatives	 14	 is	 reported.	 The	 procedure	 involves	 a	 novel	
three‐component	 reaction	 of	 2‐naphthol	 (4),	 triethyl	 ortho‐
benzoate	 (12)	 and	 acetophenone	 derivatives	 13	 in	 the	
presence	of	silica	supported	ionic	liquid	[pmim]HSO4SiO2	[silica	
supported	 1‐methyl‐3‐(triethoxysilyl‐propyl)imidazolium	
hydrogensulfate]	as	an	efficient	catalyst	(Scheme	23)	[25].	
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Scheme	23	
	
k)	A	mixture	 of	 2‐naphthol	 (4),	 aromatic	 aldehyde,	 active	
methylene	 compound,	 (malononitrile	 or	 ethyl	 cyanoacetate),	
activated	 and	 TiCl4	 (10	 mol	 %)	 was	 stirred	 at	 room	
temperature	afforded	naphthopyrans	5	(Scheme	24)	[26].	
	
	
	
Scheme	24	
	
l)	 A	 three	 component	 condensation	 aromatic	 aldehyde,	
malononitrile	 and	 2,7‐naphthalenediol	 (15),	 afforded	 only	
naphthopyran	 17,	 regardless	 of	 the	 reagent	 ratio	 (1:1:1),	
whereas	 three‐component	 condensation	 with	 the	 use	 of	 2,2‐	
naphthalenediol	(16),	gave	pyranonaphthopyran	18	regardless	
of	the	reagent	ratio	(2:2:1),	respectively,	(Scheme	25)	[27].	
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Scheme	25	
	
m)	A	wide	variety	of	2‐amino‐4H‐naphthopyran	derivatives	
5	 prepared	 via	 one‐pot,	 three‐component	 reaction	 of	 an	
aromatic	 aldehyde,	malononitrile	 (or	 ethyl	 cyanoacetate),	 and	
2‐naphthol	 (4),	 diverse	 enolizable	 C‐H	 activated	 acidic	
compounds	 in	 the	 presence	 of	 low	 loading	 of	 potassium	
phthalimide‐N‐oxyl	 (POPINO),	 as	 a	 new	 organocatalyst	
(Scheme	 26)	 [28].	 A	 mechanism	 for	 the	 POPINO	 catalyzed	
formation	 of	 the	 naphthopyran	 derivatives	 5	 is	 outlined	 in	
Scheme	27.	
	
	
	
Scheme	26	
	
	
	
Scheme	27	
n)	A	green	chemistry	method	for	synthesis	of	naphtho[2,1‐
b]pyran	 derivatives	 5	 is	 reported.	 The	 procedure	 involves	
three‐component	 reaction	 of	 2‐naphthol	 (4),	 aromatic	
aldehyde,	malononitrile	 in	 the	 presence	 of	 copper	 (II)	 sulfate	
pentahydrate,	 (Scheme	 28)	 [29].	 A	 mechanism	 for	 the	
CuSO4.5H2O	catalyzed	formation	of	the	naphtho[2,1‐b]pyrans	5	
is	outlined	in	Scheme	29.	
	
	
	
Scheme	28	
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Scheme	29	
	
2.4.	Synthesis	from	7‐substituted‐2‐naphthols		
	
Thus,	condensation	of	2,7‐naphthalenediol	(15)	or	7‐meth‐
oxy‐2‐naphthol	 (19)	 with	 α‐cyano‐4‐methoxycinnamo	 nitrile	
(2f)	 in	 ethanolic	 piperidine	 afforded	 the	 1:1	 adducts	 17,20a	
along	 with	 2‐(imino‐piperidin‐1‐yl‐methyl)‐3‐(4‐methoxy	
phenyl)‐acrylonitrile	 (21),	 while	 condensation	 of	 15	 and	 19	
with	ethyl	α‐cyano‐4‐methoxycinnamate	(2i)	afforded	20b,c	as	
the	only	isolable	products	(Scheme	30)	[30].	
	
	
	
Scheme	30	
	
2.5.	Synthesis	from	6‐bromo‐2‐naphthol		
	
Condensation	 of	 various	 substituted	 α‐cyanocinnamo	
nitriles	 (2a‐e)	 ethyl	 3‐aryl	 2‐cyano	 acrylates	 (2f‐j)	 with	 6‐
bromo‐2‐naphthol	 (22)	 in	 ethanolic	 piperidine	 afforded	
naphthopyrano	derivatives	(23a‐j)	(Scheme	31)	[31,32].	
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Scheme	31	
	
2.6.	Synthesis	from	2‐(4‐hydroxy‐3‐methoxybenzylidene)	
malononitrile	
	
The	 2‐(4‐hydroxy‐3‐methoxybenzylidene)malononitrile	
(25)	 [33]	was	 prepared	 by	 reaction	 of	 molononitrile	 with	 4‐
hydroxy‐3‐methoxy	 benzaldehyde	 (24),	 which	 upon	
condensation	 with	 2‐naphthol	 (4)	 to	 2‐amino‐3‐cyano‐4‐(4‐
hydroxy‐3‐methoxyphenyl)‐4H‐naphtho[2,1‐b]pyran	 (26),	
respectively	(Scheme	32)	[34].	
	
	
	
Scheme	32	
	
2.7.	Synthesis	from	1‐phenyl‐3‐aryl‐pyrazole‐4‐
carbaldehyde		
	
Naphthopyran	 derivatives	 28	 have	 been	 synthesized	 by	
one‐pot	 three‐component	 cyclocondensation	 reaction	 of	 1‐
phenyl‐3‐aryl‐pyrazole‐4‐carbaldehyde	(27),	malononitrile	and	
2‐naphthol	(4),	respectively	[35],	in	the	presence	of	piperidine	
as	catalyst.	The	mixture	refluxing	under	ethanol	or	acetonitrile	
gives	 moderate	 to	 good	 yield	 (50‐76%)	 (Scheme	 33).	 A	
mechanism	 for	 the	 piperidine	 catalyzed	 formation	 of	 the	
naphthopyran	derivatives	28	is	outlined	in	Scheme	34.		
	
	
	
Scheme	33	
	
	
Scheme	34	
	
	
2.8.	Synthesis	from	2‐naphthol	by	[Fe(HSO4)3]	
	
2,4‐Diaryl‐4H‐naphtho[2,1‐b]pyran	 (29)	 was	 synthesized	
by	 one‐pot	 reaction	 from	 2‐naphthol	 (4),	 aromatic	 aldehydes	
and	acetophenones	(13)	in	acetonitrile	in	the	presence	of	ferric	
hydrogensulfate.	In	the	present	study,	the	target	products	have	
been	 synthesized	 through	 new	 approach	 in	 good	 to	 excellent	
yields	 (Scheme	 35)	 [36].	 A	 mechanism	 for	 the	 Fe(HSO4)3	
catalyzed	 formation	 of	 the	 naphthopyran	 derivatives	 31	 is	
outlined	in	Scheme	36.	
	
	
	
Scheme	35	
	
	
	
Scheme	36	
	
2.9.	Synthesis	from	2‐hydroxy	naphthaldehyde	
	
a)	 Phenylsulfonylacetonitrile	 (30)	 reacts	 with	 2‐hydroxy	
naphthaldehyde	 (31)	 in	 refluxing	 ethanol	 in	 the	 presence	 of	
triethylamine	TEA	gave	2‐imino‐3‐phenylsulfonyl‐naphtho[2,1‐
b]pyran	(32),	which	by	acid	hydrolysis	gave	3‐phenylsulfonyl‐
naphtho[2,1‐b]pyran‐2‐one	(33)	(Scheme	37)	[37].	
	
	
	
Scheme	37	
	
b)	 2‐Substituted	 naphtho[2,1‐b]pyran‐2‐ones	 (35)	 have	
been	 synthesized	 by	 a	 novel	 one‐pot	 method	 which	 involves	
cyclocondensation	 of	 2‐hydroxy‐1‐naphthaldehyde	 (31)	 with	
5‐methyl‐1,3,4‐thiadiazol‐2‐ylsulfanyl‐,	 1H‐1,2,3,4‐tetrazol‐1‐
yl‐,	 1H‐indol‐3‐yl‐,	 quinolin‐8‐yloxy‐	 and	 4‐methylquinolin‐2‐
yloxy‐acetic	 acids	 (34)	 in	 the	 presence	 of	 DCC–DMSO	 using	
microwaves	as	well	as	conventional	heating	(Scheme	38)	[38].	
	
	
	
Scheme	38	
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2.10.	Synthesis	from	of	dimethyl	acetylenedicarboxylate	
(DMAD)	or	dibenzoylacetylene	
	
The	reaction	of	dimethyl	acetylene‐dicarboxylate	DMAD	or	
dibenzoylacetylene	(36)	with	tert‐butyl	 isocyanide	(37)	 in	 the	
presence	 of	 naphthols,	 proceeded	 spontaneously	 at	 room	
temperature	 in	 dichloromethane,	 and	 produced	 2‐tert‐
butylamino‐4H‐	naphtho[2,1‐b]pyrans	38‐40	(Scheme	39)	[39].	
A	mechanism	for	the	formation	of	the	pyran	derivatives,	39‐41,	
is	outlined	in	Scheme	40.	
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Scheme	39	
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Scheme	40	
	
3.	Synthesis	of	4H‐naphtho[1,2‐b]pyrans		
	
3.1.	Synthesis	from	4‐chloro‐1‐naphthol		
	
Thus,	 condensation	 of	 various	 substituted	 benzyliden	
malonitrile	(2a‐e)	and	ethyl	3‐aryl	2‐cyano	acrylates	(2f‐j)	with	
4‐chloro‐1‐naphthol	 (41)	 in	 the	 ethanolic	 piperidine	 afforded	
naphthopyran	derivatives	42a‐j	(Scheme	41)	[40,41].	
	
	
	
Scheme	41	
3.2.	Synthesis	from	4‐methoxy‐1‐naphthol	
	
Reaction	 of	 4‐methoxy‐1‐naphthol	 (43)	 with	 α‐cyano‐p‐
chlorocinnamonitrile	 (2e)	or	ethyl	α‐cyano‐p‐chlorocinnamate	
(2j)	 in	 ethanolic	 piperidine	 afforded	 naphthopyrano	 deriva‐
tives	44a,b	(Scheme	42)	[42].	
	
	
	
Scheme	42	
	
3.3.	Synthesis	from	multicomponent	reactions		
	
a)	 Naphtho[1,2‐b]pyrans	 (46)	 have	 been	 synthesized	
through	 the	 three‐component	 reaction	 of	 aromatic	 aldehydes,	
malononitrile,	and	1‐naphthol	(45)	using	a	catalytic	amount	of	
N,N‐dimethylaminoethylbenzyldimethylammonium	chloride	as	
catalyst	under	solvent‐free	condition	(Scheme	43)	[43].	
	
	
	
Scheme	43	
	
b)	Using	the	reaction	of	1‐naphthol	(45),	malononitrile	and	
aromatic	 aldehydes	 in	 the	presence	 of	 10%	mol	 of	 potassium	
phosphate	 tribasic	 trihydrate	 under	 solvent‐free	 conditions,	
afforded	 naphtho[1,2‐b]pyrans	 46	 (Scheme	 44)	 [44].	 A	
mechanism	 for	 the	 K3PO4.3H2O	 catalyzed	 formation	 of	 the	
pyran	derivatives	46	is	outlined	in	Scheme	45.	
	
	
	
Scheme	44	
	
c)	1,8‐Diazabicyclo[5.4.0]undec‐7‐ene	(DBU)	has	been	used	
as	 a	 catalyst	 for	 synthesis	 of	 naphtho[1,2‐b]pyran	 derivatives	
46	via	a	one‐pot	three‐component	reaction	of	1‐naphthol	(45),	
aromatic	 aldehydes	 and	 malononitrile/ethyl	 cyanocacetate	 in	
water	under	reflux	(Scheme	46)	[45].	A	mechanism	for	the	DBU	
catalyzed	 formation	 of	 the	 4H‐naphtho[1,2‐b]pyrans	 46	 is	
outlined	in	Scheme	47.	
	
d)	 Condensation	 of	 aromatic	 aldehyde,	 malononitrile	 and				
1‐naphthol	 (45)	 or	 4‐chloro‐1‐naphthol	 (41)	 using	Na2CO3	 as	
catalyst	afforded	naphtho[1,2‐b]pyrans	46	and	42	(Scheme	48)	
[20].		
	
e)	One‐pot,	three	components	reaction	of	1‐naphthol	(45),	
aromatic	 aldehyde	 and	 malonitrile	 in	 presences	 of	
methanesulfonic	 acid	 to	 yield	 4H‐naphtho[1,2‐b]pyrans	 46	 in	
good	yields	(Scheme	49)	[16]	.	
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Scheme	45	
	
	
	
Scheme	46	
	
f)	 A	 basic	 functionalized	 ionic	 liquid,	 1‐butyl‐3‐methyl‐
imidazolium	 hydroxide	 ([bmim]OH),	 catalyzed	 three	
component	condensation	of	aromatic	aldehydes,	malononitrile	
and	 1‐naphthol	 (45),	 proceeded	 rapidly	 in	 water	 at	 reflux	 to	
afford	 corresponding	 naphtho[1,2‐b]pyrans	46	 in	 high	 yields.	
(Scheme	50)	[19].	
	
g)	 An	 aqueous	 solution	 of	 thiourea	 dioxide	 was	 used	 to	
catalyze	 a	 one‐pot	 three‐component	 coupling	 reaction	 of	 an	
aromatic	aldehyde,	malononitrile,	and	1‐naphthol	(45),	 for	the	
synthesis	 of	 various	naphthopyran	derivatives	46	 in	 excellent	
yields	(Scheme	51)	[21].		
	
h)	Diazabicyclo[2.2.2]octane	 (DABCO)	 has	 been	 used	 as	 a	
mild	 and	 efficient	 catalyst	 for	 synthesis	 of	 2‐amino‐3‐cyano	
naphthopyran	 derivatives	 (46)	 [18]	 via	 a	 one‐pot	 three‐	
component	 reaction	 of	 aromatic	 aldehydes,	 1‐naphthol	 (45),	
and	 malononitrile	 at	 room	 temperature.	 The	 short	 reaction	
times,	easy	workup,	good	to	excellent	yields	(Scheme	52).	
	
i)	A	green	chemistry	method	for	synthesis	of	naphtho[1,2‐
b]pyrans	 (46)	 is	 reported.	 The	 procedure	 invoves	 three‐
component	 reaction	 of	 1‐naphthol	 (45),	 aromatic	 aldehyde,	
malononitrile	 in	 the	 presence	 of	 copper(II)sulfate	 penta	
hydrate,	(Scheme	53)	[29].	
	
j)	A	wide	variety	of	naphtho[1,2‐b]pyrans	46	prepared	via	
one‐pot,	 three‐component	 reaction	 of	 an	 aromatic	 aldehyde,	
malononitrile	 (or	ethyl	 cyanoacetate),	 and	1‐naphthol	 (45),	 in	
the	 presence	 of	 low	 loading	 of	 potassium	 phthalimide‐N‐oxyl	
(POPINO),	as	a	new	organocatalyst	(Scheme	54)	[28].	
	
	
Scheme	47	
	
	
	
Scheme	48	
	
	
	
Scheme	49	
	
	
	
Scheme	50	
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Scheme	51	
	
	
	
Scheme	52	
	
	
Scheme	53	
	
	
	
	
Scheme	54	
	
k)	A	simple	and	efficient	 three	component	process	for	 the	
synthesis	 of	 naphtho[1,2‐b]pyrans	 46	 and	 47	 utilizing	 the	
reaction	 of	 aryl	 with	 active	 methylenes	 (malononitrile,	 2‐
cyanoethyanethioamide)	 and	 1‐naphthol	 (45),	 in	 refluxing	
ethanol/piperidine	 under	 microwave‐heating	 is	 described	
(Scheme	55)	[46].		
	
	
	
Scheme	55	
	
l)	 Mg/Al	 hydrotalcite,	 a	 heterogeneous	 base	 catalyst,	 was	
found	 to	 be	 highly	 effective	 for	 the	 synthesis	 of	 naphtho[1,2‐
b]pyrans	 46	 via	 a	 multicomponent	 reaction	 of	 aromatic	
aldehydes,	 malononitrile	 and	 1‐naphthol	 (45)	 under	
microwaves.	The	reaction	is	rapid,	clean	and	gives	the	products	
in	 high	 yields.	 The	 catalyst	 is	 reusable;	 however,	 there	 was	
reduction	in	the	yield	of	the	product	(Scheme	56)	[47].	
	
	
	
Scheme	56	
	
m)	 One	 pot	 multicomponent,	 condensation	 reaction	 of							
1‐naphthol	 (45)	 aldehyde	 and	 malononitrile	 using	 catalytic	
amounts	 tetrabutyl	 ammonium	 bromide	 (TBABr)	 under	
microwaves	 aqueous	 conditions	 afforded	 naphthopyrans	 46	
(Scheme	57)	[17].	
		
	
	
Scheme	57	
	
n)	Maggi	et	al.	[48]	have	described	the	use	of	basic	alumina	
as	 a	 heterogeneous	 and	 reusable	 catalyst	 for	 the	 three‐
component	 synthesis	 of	 substituted	 naphtho[1,2‐b]pyrans	46.	
The	 reaction	 is	 highly	 regioselective.	 This	 process	 is	
industrially	 viable	 due	 to	 the	 use	 of	 water	 as	 a	 solvent	 and								
γ‐alumina	 as	 an	 inexpensive	 and	 reusable	 catalyst.	 However,	
one	drawback	of	this	methodology	is	1‐naphthol	(45)	can	only	
be	 used	 as	 an	 activated	 phenol.	 The	 preparation	 of	 these	
compounds	 has	 also	 been	 reported	 by	Wang	 et	al.	 [49]	 using	
KF‐alumina	as	a	catalyst	(Scheme	58).	
	
	
	
Scheme	58	
	
o)	 A	 facile	 method	 for	 the	 synthesis	 of	 naphtho[1,2‐
b]pyrans	48	is	reported.	The	procedure	involves	a	novel	three‐
component	 reaction	 of	 1‐naphthol	 (45),	 triethyl	 ortho	
benzoate(12)	 and	 acetophenone	 derivatives	 13,	 in	 the	
presence	 of	 silica	 supported	 ionic	 liquid	 [pmim]HSO4	 SiO2	
[silica	 supported	 1‐methyl‐3‐(triethoxysilyl‐propyl)imidazo	
lium	hydrogen‐sulfate]	(Scheme	59)	[25].	
	
	
	
Scheme	59	
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3.4.	Synthesis	from	1‐phenyl‐3‐aryl‐pyrazole‐4‐
carbaldehyde		
	
Naphthopyran	 derivatives	49a‐g	has	 been	 synthesized	 by	
one‐pot	 three‐component	 cyclocondensation	 reaction	 of	 1‐
phenyl‐3‐aryl‐pyrazole‐4‐carbaldehyde	 (27a‐g),	 malononitrile	
and	1‐naphthol	(45),	respectively,	in	the	presence	of	piperidine	
as	catalyst	(Scheme	60)	[35].	
	
	
	
Scheme	60	
	
3.5.	Synthesis	from	1‐naphthol	by	[Fe(HSO4)3]	
	
Synthesis	 of	 2,4‐diaryl‐4H‐	 naphtho[1,2‐b]pyrans	 50	 by	
one‐pot	 reaction	 from	 1‐naphthol	 (45)	 ,	 aromatic	 aldehydes	
and	 acetophenone	 in	 acetonitrile	 in	 the	 presence	 of	 ferric	
hydrogen	sulfate.	In	the	present	study,	the	target	products	have	
been	 synthesized	 through	 new	 approach	 in	 good	 to	 excellent	
yields	(Scheme	61)	[36].	
	
	
	
Scheme	61	
	 	
3.6.	Synthesis	from	of	dimethyl	acetylenedicarboxylate	
DMAD	or	dibenzoylacetylene		
	
The	 reaction	of	dimethyl	 acetylenedicarboxylate	DMAD	or	
dibenzoylacetylene	(36)	with	tert‐butyl	 isocyanide	(37)	 in	 the	
presence	of	1‐naphthol	(45),	proceeded	spontaneously	at	room	
temperature	 in	 dichloromethane,	 and	 produced	 2‐tert‐
butylamino‐4H‐naphtho[1,2‐b]pyrans	52	(Scheme	62)	[39].	
	
	
	
Scheme	62	
	
3.7.	Synthesis	from	ethylacetoacetate	
	
Formation	 of	 4‐methyl‐naphtho[1,2‐b]pyran‐2‐one	 (53)	
takes	 place	 via	 cyclization	 reaction	 of	 1‐naphthol	 (45)	 and	
ethylacetoacetate	 (52)	 in	presence	 of	 sulphuric	 acid.	 (Scheme	
63)	[50].	
	
	
	
Scheme	63	
	
4.	Reactions	of	naphtho[2,1‐b]pyrans	and	naphtha														
[1,2‐b]pyrans	with	some	electrophilic	and	nucleophilic	
reagents	
	
4.1.	Reactions	of	naphthopyranoaminonitriles	
	
4.1.1.	Acetic	anhydride	 	
	
Treatment	 of	 naphtho[2,1‐b]pyran	 3,	 5	 and	 23	 and	 or	
naphtho[1,2‐b]‐pyran	 42	 and	 44	 derivatives	 with	 Ac2O	 gave	
two	 products	 dependening	 on	 the	 reaction	 time;	 one	 product	
was	identified	as	2‐acetylamino‐naphthopyrans	derivatives	54	
and	 56	 (30	 min),	 while	 the	 other	 was	 identified	 as	
naphthopyranopyrimidine	 derivatives	 55	 and	 57	 (6	 h)	
(Scheme	64)	[11‐13,30‐33,40‐42].		
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Scheme	64	
	
4.1.2.	Formic	acid	or	benzoyl	chloride	
	
Reaction	 of	 naphtho[2,1‐b]pyrans	 3,	 5	 and	 23	 and	 or	
naphtho[1,2‐b]‐pyran	42	 and	44	derivatives	with	 formic	 acid	
or	 benzoyl	 chloride	 to	 give	 naphthopyranopyrimidine	 and	
phenyl‐naphthopyranopyrimidine	derivatives	58	and	59	 (6h),	
respectively	(Scheme	65)	[11‐13,30‐33,40‐42].	
	
	
	
Scheme	65	
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4.1.3.	Formamide	
	
Reaction	 of	 naphtho[2,1‐b]pyrans	 3,	 5	 and	 23	 and	 or	
naphtho[1,2‐b]‐pyran	42	and	44	derivatives	with	formamide	to	
give	 aminonaphtho‐pyranopyrimidine	 derivatives	 60	 and	 61	
(Scheme	66)	[11‐13,30‐33,40‐42].	
	
	
	
Scheme	66	
	
4.1.4.	Carbon	disulfide	or	phenyl	isothiocyanate	[13]	
	
Treatment	 of	 compound	 5	 with	 carbon	 disulphide	 in	
alcoholic	 postassium	 hydroxide	 furnished	 9,11‐dithione	
derivative	62,	 whereas	 treatment	 with	 phenyl	 isothiocyanate	
yielded	the	9‐thione	derivative	63	(Scheme	67)	[13].	
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Scheme	67	
	
4.1.5.	Aromatic	aldehyde		
	
Condensation	 of	 compound	 43	 with	 benzaldehyde	 or	 4‐
methyloxy‐benzaldehyde	 in	 dioxin‐	 piperidine	 solution	 under	
reflux	 afforded	 the	 corresponding	 arylmethyleneamino	
derivatives	64a‐f	(Scheme	68)	[41].	
	
	
	
Scheme	68	
	
4.1.6.	Triethyl	orthoformate	
	
Ethoxymethylene	 derivatives	65	 and	66	 was	 obtained	 by	
refluxing	 compounds	 naphthopyrano	 derivatives	3,	5,	22,	42	
and	 44,	 with	 triethyl	 orthoformate	 as	 electrophile	 in	 the	
presence	of	acetic	anhydride	(Scheme	69)	[11‐13,30‐33,40‐42].	
	
	
Scheme	69	
	
Treatment	of	65	and	66	with	hydrazine	hydrate	in	ethanol,	
at	 room	 temperature	 furnished	 the	 novel	 naphthopyrano	
pyrimidine	 derivatives	 67	 and	 69	 in	 good	 yield.	 Also,	
compound	 64	 and	 65	 underwent	 aminolysis	 and	 cyclization	
with	 primary	 amine,	 while	 with	 dimethylamine	 the	 opene‐
chain	 product	68	 and	70.	 Ammonolysis	 of	 compound	64	 and	
65	 in	 methanol	 at	 room	 temperature	 afforded	 amino‐
naphthopyranpyrimidine	 derivatives	60	 and	 61	 (Scheme	 70)	
[11‐13,30‐33,40‐42].	
	
	
	
Scheme	70	
	
Reaction	of	naphthopyranpyrimidine	derivatives	67	and	68	
with	 formic	 acid	 or	 triethyl	 orthoformate,	 acetylchloride	 and	
benzoyl	 chloride,	 ethyl	 cyanoacetate	 and	 diethyl	 oxalate	
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afforded	 the	 corresponding	 triazolopyrimidine	 derivatives	73	
and	74	(Scheme	71)	[11‐13,30‐33,40‐42].	
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Scheme	71	
	
Treatment	 of	67	 and	68	 with	 ethyl	 chloroformate	 in	 dry	
benzene	afforded	traizolo‐2‐one	derivative	75	and	76	(Scheme	
72)	[11‐13,30‐33,40‐42].		
	
	
	
Scheme	72	
	
Reaction	of	compound	67	and	68	with	benzaldehyde	gave	
10‐benzalamino‐10,11‐dihydro‐11‐imino‐3‐methoxy‐12‐(aryl)‐
12H‐naphtho‐[2,1‐b]pyrano‐[2,3‐d]pyrimidine	 (77	 and	 78)	
instead	 of	 the	 expected	 triazolopyrimidine	 derivative	 72	 and	
73	(Scheme	73)	[11,13,30‐33,40‐42].	
	
	
	
Scheme	73	
	
4.1.7.	Active	methylene	reagents		
	
Compound	2‐(3‐amino‐2‐cyano‐1H‐benzo[f]chromen‐1‐yl)‐
malononitrile	 (79)	 was	 condensed	 with	 different	 active	
methylene	reagents	such	as	methyl	3‐oxobutanoate	(80b),	2,4‐
pentanedione	 (80c)	and	1,3‐diphenyl‐1,3‐propanedione	 (80d)	
to	 give	 the	 corresponding	 pentacyclic	 compounds	 82b‐d	
(Scheme	74).	According	to	the	literature	results	[52,53‐55]	the	
heterocycles	 obtained	 in	 the	 reaction	 between	 aminonitriles	
and	 β‐dicarbonyles	 is	 formed	 via	 the	 intermediate	 β‐
enaminodiones	 (81).	 These	 intermediates	 have	 never	 been	
isolated	possibly	due	to	their	fast	intramolecular	cyclization	to	
heterocyclic	rings.		
Therefore,	 the	 structure	 of	 compounds	 82a‐d	 is	
rationalized	 in	 terms	 of	 the	 initial	 formation	 of	 the	
intermediate	 81,	 which	 on	 subsequent	 intramolecular	
cyclization	 followed	 by	 elimination	 of	 a	 water	 molecule	 and	
partial	dehydrogenation	under	 the	 reaction	conditions	affords	
the	final	product	(Scheme	74)	[51].	
In	 a	 similar	 manner,	 compound	 79	 condensed	 with	
benzoylacetonitrile	 (80e)	 under	 the	 previous	 reaction	
conditions	 to	yield	 a	product	 formulated	as	82e	 (Scheme	74).	
Moreover,	 a	 mixture	 of	 equimolar	 amounts	 of	 compound	 79	
and	malononitrile	(80f)	reacted	in	refluxing	ethanol	and	in	the	
presence	 of	 a	 catalytic	 amount	 of	 piperidine	 to	 yield	 a	 solid	
product	 naphthyridine	 84	 (route	 A)	 or	 pyridopyrimidine	 86	
(route	B)	(Scheme	74).	Thus	it	appears	that	the	dicyanomethyl	
anion	attacks	 the	cyano	group	of	79	yielding	 the	 intermediate	
83	 (route	 A)	 which	 by	 intra‐molecular	 cyclization	 between	
amino	 and	 cyano	 groups	with	 partial	 dehydrogenation	 under	
the	reaction	conditions	gives	compound	84	(Scheme	74)	[51].	
	
	
	
Scheme	74	
	
2‐Amino‐5‐methyl‐benzo[5,6]chromeno[4,3,2‐de]1,6]napht	
hyridine‐1,4‐dicarbonitrile	 (89)	 was	 obtained	 when	 79	 was	
heated	under	reflux	with	3‐amino‐crotononitrile	(87)	in	boiling	
ethanol.	 The	 formation	 of	 compound	 89	 can	 be	 described	 in	
terms	of	 the	 initial	 formation	of	 the	 intermediate	88	 followed	
by	its	cyclization	to	the	final	product	89	(Scheme	75).		
Trinitriles	 79	 reacted	 with	 ammonium	 acetate	 in	 molar	
ratio	 1:2	 to	 afford	 2,6‐diamino‐4‐(2‐hydroxy‐1‐naphthyl)‐3,5‐
pyridine‐dicarbonitrile	 (90).	 Compound	90	was	 converted,	 in	
the	presence	of	 hydrochloric	 acid,	 into	2,4‐diamino‐5‐oxo‐5H‐
benzo[5,6]chromeno[3,4‐c]pyridine‐1‐carbonitrile	(92),	presu‐
meably	 the	 imino	 group	 in	 the	 postulated	 intermediate	91	 is	
hydrolysed	during	formation	of	92	(Scheme	75).	
	
4.1.8.	Cyclohexanone		
	
The	 cyclocondensation	 of	 2‐amino‐3‐cyano‐4H‐4‐aryl‐
naphthopyran	derivatives	5	with	cyclohexanone	(93)	in	DMF	in	
the	presence	of	anhydrous	zinc	chloride	under	reflux	gave	two	
different	 skeletons	 compounds,	 one	 is	 quinolines	 94	
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(tacrineanalogues)	 from	 the	 famous	 Friendlander	 conden‐
sation,	 and	 another	 one	 is	 the	 spiro	 compound	95	 from	 new	
annulation	(Scheme	76).	A	plausible	mechanism	was	proposed	
(Scheme	77)	[56].	
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Scheme	76	
	
4.2.	Reactions	of	naphthopyranoaminoester	
	
4.2.1.	Dimethyl	formamide		
	
Reaction	 of	 ethyl	 2‐amino‐4‐phenyl‐4H‐naphtho[2,1‐
b]pyran‐2‐carboxylate	 (5)	 with	 dimethyl	 formamide	 in	
presence	 of	 phosphorus	 oxychloride,	 afforded	 ethyl	
2‐(dimethylaminomethyleneamino)‐4‐phenyl‐4H‐naphtho[2,1‐
b]pyran	 ‐3‐carboxylate	 (96)	 (Scheme	 78).	 Thus,	 treatment	 of	
compound	 96	 with	 aromatic	 amine	 in	 refluxing	 ethanol	
afforded	 2‐(phenylaminomethyleneamino)‐4‐phenyl‐4H‐naph‐
tho[2,1‐b]pyran‐3‐carboxylic	acid	(98).	So,	it	was	assumed	that	
the	reaction	proceeded	via	losing	N‐dimethylamine	to	give	the	
intermediate	 97	 which	 underwent	 hydrolysis	 rather	 than	
cyclization	 via	 losing	 ethanol	 yielding	 what	 we	 expected	 as	
product	98,	(Scheme	78)	[57].	While	repeating	this	reaction	in	
pyridine	 at	 reflux	 for	 five	 hours	 afforded	 the	 expected	 10,12‐	
diphenyl‐12H‐	 naphtho[2,1‐b]pyrano[2,3‐d]pyrimidine‐11‐one	
(99).	 Compound	96	 formed	 via	 losing	 of	N‐dimethylamine	 to	
give	 the	 intermediate	97	 which	 cyclized	 through	 releasing	 of	
ethanol.	 On	 the	 other	 hand,	 compound	 96	 reacted	 with	
substituted	hydrazine	to	yield	the	corresponding	naphtho[2,1‐
b]pyrano[2,3‐d]pyrimidine	 derivatives	 101a,b	 via	 elimination	
of	 ethanol	 from	 the	 corresponding	 intermediate	 100	 which	
cyclized	via	release	of	ethanol	[57].	
	
	
	
Scheme	77	
	
	
	
Scheme	78	
	
4.2.2.	With	carbon	disulfide		
	
A	solution	of	compound	5	in	dimethyl	sulfoxide	was	treated	
with	carbon	disulfide	in	presence	of	sodium	hydroxide	solution.	
The	 sodium	 salt	 of	 dithiocarbamic	 acid,	102,	was	 obtained	 in	
situ	 and	 then	methylated	with	 dimethyl	 sulfate	 to	 yield	 ethyl	
2‐(methylsulfanylthiocarbonylamino)‐4‐phenyl‐4H‐naphtho[2,
1‐b]pyran‐3‐carboxylate	 (104),	 but	 non‐isolable	 compound	
103.	The	compound	104	when	reacted	with	hydrazine	hydrate	
in	ethanol	with	stirring	at	room	temperature	yielded	the	open	
chain	 thiosemicarbazide	 derivative	 105	 via	 elimination	 of	
methylsulfane,	 while,	 under	 reflux	 in	 ethanol	 for	 8	 hours,	 it	
yielded	 the	 expected	 naphtho[2,1‐b]pyrano[2,3‐d]pyrimidine	
106	 via	 elimination	 of	methylsulfane	 and	 ethanol.	 Boiling	 the	
thiosemicarbazide	105	 in	ethanol	in	presence	of	triethylamine	
yielded	the	same	compound	106	(Scheme	79)	[57].	
Compound	 106	 was	 allowed	 to	 react	 with	 benzaldehyde	
and/or	 4‐chlorobenzaldehyde	 to	 give	 the	 corresponding	
expected	 Schiff's	 base	107.	However,	 the	 isolated	 compounds	
proved	 to	 be	 the	 new	 and	 unexpected	 compounds	 108a,b	
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formed	via	simultaneous	nucleophilic	attack	of	the	sulfur	atom	
on	 the	 hydrazone	 carbon	 with	 cyclization	 to	 the	 new	
thiadiazole	derivatives	108a,b,	as	shown	in	(Scheme	80)	[57].	
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Scheme	79	
	
	
	
Scheme	80	
	
Furthermore	 compound	 5,	 when	 treated	 with	 carbon	
disulfide	and	potassium	hydroxide	solution,	yielded	the	soluble	
potassium	salt	of	dithiocarbamic	acid,	109,	which	was	 further	
treated	 in	 situ	 with	 chloroacetic	 acid	 and	 phenacylbromide,	
respectively,	 to	 afford	 ethyl	 2‐(4‐oxo‐2‐thioxothiazolidin‐3‐yl)	
‐4‐phenyl‐4H‐naphtho[2,1‐b]pyran‐3‐carboxylate	 (111)	 and	
4‐phenyl‐2‐(4‐phenyl‐2‐thioxothiazol‐3(2H)‐yl)‐4H‐naphtha[2,	
1‐b]pyran	 ‐3‐carboxylate	 (113)	 via	 release	 of	water	 from	 the	
two	 corresponding	 intermediates	 110	 and	 112,	 respectively,	
(Scheme	81)	[57].	
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Scheme	81	
	
4.2.3.	Acetic	anhydride		
	
Compound	5	 was	 acylated	with	 acetic	 anhydride	 yielding	
the	acetyl	derivative,	114,	which	easily	reacted	with	hydrazine	
hydrate	 to	 afford	 the	 new	 substituted	 10‐amino‐9‐	
methyl‐12‐phenyl‐12H‐naphtho[2,1‐b]pyrano[2,3‐d]‐pyrimidi	
ne‐11‐one	(116)	via	intermediate	115	which	formed	from	114	
by	 displacement	 of	 ethanol	 rather	 than	 water	 as	 shown	 in	
(Scheme	82)	[57].	
	
5.	Applications	of	naphthopyrans	
	
Naphtho[2,1‐b]pyran	 derivatives	 3,	 5	 and	 23	 and	
naphtho[1,2‐b]pyran	 derivatives	 42	 were	 found	 exhibited	
inhibition	 antibacterial	 activities	 (Scheme	 83)	 [11‐13,23‐
26,33].	
4‐Aryl‐2‐amino‐5,6‐dihydro‐4H‐naphtho[1,2‐b]pyran‐3‐
carbonitrile	 derivatives,	 117,	 have	 antiproliferative	 activities	
(Scheme	84)	[58,59].	
4‐(Piperazin‐1‐yl)‐4H‐naphtho[2,1‐b]pyran‐2‐one,	 4‐
(piperazin‐1‐yl)‐4H‐naphtho[1,2‐b]pyran‐2‐one,	 and	 4‐
(piperazin‐1‐yl)‐4H‐naphtho[2,3‐b]‐pyran‐2‐one	 (118‐120)	
have	antiplatelet	agents	(Scheme	85)	[60].	
3,3‐Dihydro‐2,2‐dimethyl‐4H‐naphtho[1,2‐b]pyran‐4‐
one	(121)	was	hypotensive	action	(Scheme	86)	[61].		
4‐Methyl‐7‐hydroxy‐4H‐naphtho[1,2‐b]pyran‐2‐one	 (122)	
as	used	fluorescence	reagents	(Scheme	87)	[62].	
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Scheme	85	
	
	
	
Scheme	86	
	
3,4‐Dihydro‐2,2‐dimethyl‐4‐(2‐oxo‐pyrrolidin‐1‐yl)‐4H‐
naphtho[1,2‐b]pyran‐6‐carbonitrile	(123)	and	3,4‐dihydro‐2,2‐
dimethyl‐4‐(2‐oxo‐pyridin‐1‐yl)‐4H‐naphtho[1,2‐b]pyran‐6‐
carbonitrile(124)	 were	 promised	 vasorelaxant	 activity	
(Scheme	88)	[63].		
	
	
	
Scheme	87	
	
The	photochromic	properties	of	naphthopyrans	(125)	have	
been	 extensively	 studied	 in	 the	 last	 decade	 due	 to	 the	 wide	
range	 of	 applications	with	 prominence	 in	 the	manufacture	 of	
ophthalmic	plastic	lenses	and	solar	protection	glasses	(Scheme	
89)	[64‐67].	
	
	
Scheme	88	
	
	
	
Scheme	89	
	
6‐Acetoxy‐3‐(4‐(2,5‐dihydro‐2,5‐dioxo‐1H‐pyrrol‐1‐yl)	
phenyl)‐4H‐naphtho[2,1‐b]pyran‐2‐one	 (126)	 show	 have	
cytoxicity	activities	(Scheme	90)	[68].	
	
	
	
Scheme	90	
 
7‐Hydroxy‐4‐methyl‐naphtho[1,2‐b]pyran‐2‐one‐8,10‐di	
carbaldehyde	 (127)	 as	 potential	 antidyslipidemic	 and	
antioxidant	agents	(Scheme	91)	[69].	
	
	
	
Scheme	91	
	
2‐Amino‐4a,5,6,10b‐tetrahydro‐4‐(3‐(trifluoromethyl)	
phenyl)‐4H‐naphtho[1,2‐b]pyran‐3‐carbonitrile	 (128)	 show	
have	rheumatoid	arthritis	(Scheme	92)	[70,71].		
	
	
	
Scheme	92	
	
2‐Amino‐4‐(pyridine‐3‐yl)‐4H‐naphtho[1,2‐b]pyran‐3‐
carbonitrile	(129)	show	have	restenosis	(Scheme	93)	[72‐75].	
	
	
	
Scheme	93	
	
2‐Amino‐4‐(3‐nitrophenyl)‐4H‐naphtho[1,2‐b]pyran‐3‐
carbonitrile	 (130),	 4‐(3‐nitrophenyl)‐2‐(1H‐pyrrol‐1‐yl)‐4H‐	
naphtho[1,2‐b]pyran‐3‐carbonitrile	 (131)	 and	 4‐(3‐nitro	
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phenyl)‐2‐(2,5‐dioxopyrrolidin‐1‐yl)‐4H‐	naphtho[1,2‐b]pyran‐
3‐carbonitrile	(132)	show	have	diabetic	complications	(Scheme	
94)	[76,77].	
	
	
	
Scheme	94	
	
6.	Conclusions	
	
Naphthopyran	 derivatives	 have	 been	 reported	 in	 the	
literatures	 as	 a	 result	 of	 fusion	 of	 naphthalene	moiety	 to	 the	
pyran	ring	and	were	synthesized	either	starting	with	naphthols	
and	 arylidene	 in	 presence	 catalyst.	 Also	 naphthopyran	
derivatives	 were	 prepared	 by	 multicomponent	 reactions	
(Aromatic	 aldehyde,	 naphthols,	 active	methylene	 compounds)	
in	presence	catalyst.	Naphthopyran	derivatives	described	have	
been	reported	to	furnish	interesting	biological	properties.	
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